uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Pfizer Stock Climbs With Positive Renal Cancer Phase III Data July 8, 2016 Cytokinetics Scraps Lead ALS Drug After Late-Stage Trial Failure November 20, 2017 Why Amazon Could be More Interested in Medical Devices Than Drugs October 29, 2017
